Comparison of sequential therapy and amoxicillin/tetracycline containing bismuth quadruple therapy for the first-line eradication of Helicobacter pylori: a prospective, multi-center, randomized clinical trial

被引：0
|
作者：
Ju Yup Lee
Nayoung Kim
Kyung Sik Park
Hyun Jin Kim
Seon Mee Park
Gwang Ho Baik
Ki-Nam Shim
Jung Hwan Oh
Suck Chei Choi
Sung Eun Kim
Won Hee Kim
Seon-Young Park
Gwang Ha Kim
Bong Eun Lee
Yunju Jo
Su Jin Hong
机构：
[1] Seoul National University Bundang Hospital,Department of Internal Medicine
[2] Keimyung University School of Medicine,Department of Internal Medicine
[3] Gyeongsang National University School of Medicine,Department of Internal Medicine and Institute of Health Science
[4] College of Medicine,Department of Internal Medicine
[5] Chungbuk National University,Department of Internal Medicine
[6] Hallym University College of Medicine,Department of Internal Medicine
[7] Chuncheon Sacred Heart Hospital,Departments of Internal Medicine, College of Medicine
[8] Ewha Womans University School of Medicine,Department of Internal Medicine
[9] The Catholic University of Korea,Department of Internal Medicine
[10] Wonkwang University School of Medicine,Digestive Disease Center, CHA Bundang Medical Center
[11] Kosin University College of Medicine,Department of Internal Medicine
[12] CHA University,Department of Internal Medicine
[13] Chonnam National University Medical School,Department of Internal Medicine
[14] Pusan National University School of Medicine and Biomedical Research Institute,Department of Internal Medicine and Research Institute
[15] Pusan National University Hospital,undefined
[16] Eulji General Hospital,undefined
[17] Eulji University School of Medicine,undefined
[18] Soonchunhyang University College of Medicine,undefined
来源：
BMC Gastroenterology | / 16卷
关键词：
Eradication; Amoxicillin; Tetracycline; Bismuth; Quadruple;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Bismuth, esomeprazole, metronidazole, and minocycline or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial
    Suo, Baojun
    Tian, Xueli
    Zhang, Hua
    Lu, Haoping
    Li, Cailing
    Zhang, Yuxin
    Ren, Xinlu
    Yao, Xingyu
    Zhou, Liya
    Song, Zhiqiang
    CHINESE MEDICAL JOURNAL, 2023, 136 (08) : 933 - 940
  • [22] Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori
    Ciccaglione, Antonio Francesco
    Cellini, Luigina
    Grossi, Laurino
    Marzio, Leonardo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (32) : 4386 - 4390
  • [23] High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial
    Yu, Lou
    Luo, Laisheng
    Long, Xiaohua
    Liang, Xiao
    Ji, Yingjie
    Graham, David Y.
    Lu, Hong
    HELICOBACTER, 2019, 24 (04)
  • [24] The Efficacy of Bismuth Quadruple Therapy, Sequential Therapy, and Hybrid Therapy as a First-Line Regimen for Helicobacter pylori Infection Compared with Standard Triple Therapy
    Koroglu, M.
    Ayvaz, M. A.
    Ozturk, M. A.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2022, 25 (09) : 1535 - 1541
  • [25] Modified bismuth quadruple therapy with low-dose metronidazole as first-line therapy for Helicobacter pylori infection
    Pih, Gyu Young
    Choi, Kee Don
    Gong, Eun Jeong
    Na, Hee Kyong
    Ahn, Ji Yong
    Lee, Jeong Hoon
    Jung, Kee Wook
    Kim, Do Hoon
    Song, Ho June
    Lee, Gin Hyug
    Jung, Hwoon-Yong
    HELICOBACTER, 2021, 26 (01)
  • [26] Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
    Veysari, Arash Kazemi
    Rahimi, Ali
    Maleki, Iradj
    Fakheri, Hafez Tirgar
    Taghvaei, Tarang
    Hosseini, Vahid
    Toosi, Seyed Mohammad Valizadeh
    Masoumi, Danial
    Bari, Zohreh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (04) : 676 - 680
  • [27] Bismuth, rabeprazole, amoxicillin, and doxycycline as first-line Helicobacter pylori therapy in clinical practice: A pilot study
    Gu, Lei
    Li, Shenglan
    He, Ying
    Chen, Yi
    Jiang, Yanzhi
    Peng, Yu
    Liu, Xiaowei
    Yang, Huixiang
    HELICOBACTER, 2019, 24 (04)
  • [28] Efficacy and Safety of Modified Bismuth Quadruple Therapy for First-Line Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Cho, Jun-Hyung
    Jin, So-Young
    MICROORGANISMS, 2025, 13 (03)
  • [29] Multiple Bismuth Quadruple Therapy Containing Tetracyclines Combined with Other Antibiotics and Helicobacter pylori Eradication Therapy
    Sun, Yingchao
    Zhu, Mengjia
    Yue, Lei
    Hu, Weiling
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [30] Saccharomyces boulardii Combined With Quadruple Therapy for Helicobacter pylori Eradication Decreased the Duration and Severity of Diarrhea: A Multi-Center Prospective Randomized Controlled Trial
    Zhao, Yuchong
    Yang, Yilei
    Aruna
    Xiao, Jun
    Song, Jun
    Huang, Tizheng
    Li, Shuyu
    Kou, Jiguang
    Huang, Lu
    Ji, Dexiong
    Xiong, Si
    Peng, Wang
    Xu, Sanping
    Cheng, Bin
    FRONTIERS IN MEDICINE, 2021, 8
12345